Guardian Wealth Advisors (North Carolina)’s CVS Health CVS Stock Holding History

Guardian Wealth Advisors (North Carolina)’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$280K	Buy	+2,707	New	+$242K	0.02%	321
2026 Q1	–	Sell	-2,751	Closed	-$218K	–	617
2025 Q4	$218K	Buy	2,751 +11	+0.4%	+$867	0.01%	348
2025 Q3	$207K	Buy	+2,740	New	+$188K	0.01%	343
2024 Q2	–	Sell	-5,203	Closed	-$415K	–	440
2024 Q1	$415K	Buy	5,203 +256	+5%	+$19.6K	0.05%	179
2023 Q4	$391K	Sell	4,947 -451	-8%	-$32.1K	0.06%	165
2023 Q3	$377K	Sell	5,398 -628	-10%	-$44.5K	0.06%	153
2023 Q2	$417K	Buy	6,026 +2	+0%	+$142	0.07%	143
2023 Q1	$448K	Buy	6,024 +828	+16%	+$69.4K	0.08%	130
2022 Q4	$484K	Buy	5,196 +139	+3%	+$13.4K	0.09%	115
2022 Q3	$482K	Buy	5,057 +1,353	+37%	+$134K	0.09%	106
2022 Q2	$343K	Buy	3,704 +633	+21%	+$61.8K	0.06%	132
2022 Q1	$311K	Buy	+3,071	New	+$323K	0.13%	117

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Guardian Wealth Advisors (North Carolina)'s CVS Position: Q2 2026 in Review

Guardian Wealth Advisors (North Carolina) opened a new position in CVS Health (CVS) in Q2 2026: 2,707 shares worth $280K. The stake represents 0.02% of the portfolio and ranks #321 among its holdings. This is a return to the name: Guardian Wealth Advisors (North Carolina) previously reported a position in CVS as recently as Q4 2025.

Guardian Wealth Advisors (North Carolina) first reported a position in CVS in Q1 2022 and has held it in 12 quarters since. The position peaked at $484K in Q4 2022. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Guardian Wealth Advisors (North Carolina) held 2,707 shares of CVS Health worth $280K as of Q2 2026.
CVS Health was a new Guardian Wealth Advisors (North Carolina) position in Q2 2026.
CVS Health made up 0.02% of Guardian Wealth Advisors (North Carolina)'s portfolio in Q2 2026, its #321 holding.
Guardian Wealth Advisors (North Carolina) first reported a position in CVS Health in Q1 2022 and has held it in 12 quarters since.
Guardian Wealth Advisors (North Carolina)'s CVS Health position peaked at $484K in Q4 2022.
2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Guardian Wealth Advisors (North Carolina)'s 13F filing for Q2 2026, filed 14 Aug 2026.